Parabilis Medicines (NASDAQ:PBLS) Stock Price & Analysis

$36.88

USD

+0.56(1.54%)

At close: Sep 12, 03:02 EDT

Open

$29.58

Prev. Close

$36.32

High

$30.00

Low

$28.15

Company Profile

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.

CEOMathai Mammen

SectorHealthcare

IndustryBiotechnology

Employees145

Recently from Cashu

IPO Date

Jun 10, 2026

ExchangeNASDAQ

Exchange NameNASDAQ

CurrencyUSD

Headquarters & Contact

Address30 Acorn Park Dr

City / State / ZIPCambridge, MA, 02140

CountryUnited States

Websitehttp://www.parabilismed.com

Parabilis Medicines, Inc.

Company Profile

Recently from Cashu